Try our beta test site
26 studies found for:    epilepsy | "Dravet Syndrome"
Show Display Options
Rank Status Study
1 Available Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
Conditions: Dravet Syndrome;   Epileptic Encephalopathies Associated With SCN1A Mutations
Intervention: Drug: Stiripentol
2 No longer available Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: stiripentol
3 Recruiting Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Device: measure of neuronal excitability
4 Completed Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
5 Recruiting Cardiac Arrhythmias in Dravet Syndrome
Condition: Epilepsy
Intervention:
6 Recruiting Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome
Condition: Epilepsy
Interventions: Drug: ataluren;   Drug: Placebo
7 Recruiting GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo Control
8 Completed A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
9 Not yet recruiting The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy
Conditions: Dravet Syndrome;   Lennox Gastaut Syndrome
Intervention:
10 Recruiting A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
Conditions: Dravet Syndrome;   Seizure Disorder
Interventions: Drug: ZX008 (Fenfluramine Hydrochloride);   Drug: Matching Placebo
11 Recruiting Genetic Analysis Between Charlotte's Web Responders Versus Non- Responders in a Dravet Population
Condition: Dravet Syndrome
Intervention:
12 Not yet recruiting The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy
Conditions: Lennox-Gastaut Syndrome;   Dravet Syndrome
Interventions: Procedure: 15-Lead ECG;   Drug: Cannabadiol
13 Enrolling by invitation An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: ZX008 (Fenfluramine Hydrochloride)
14 Recruiting A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: ZX008 - 0.8 mg/kg/day;   Drug: ZX008 - 0.2 mg/kg/day;   Drug: Placebo
15 Recruiting A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: ZX008 - 0.2 mg/kg/day;   Drug: ZX008 - 0.4 mg/kg/day;   Drug: ZX008 - 30 mg/kg/day maximum dose;   Drug: Matching Placebo
16 Enrolling by invitation An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
Conditions: Epilepsy;   Dravet Syndrome;   Lennox-Gastaut Syndrome
Intervention: Drug: GWP42003-P
17 Available Compassionate Use of Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
18 Completed Verapamil as Therapy for Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Verapamil
19 Available Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
20 Withdrawn Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: Clobazam;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.